{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:02:08Z","timestamp":1792202528085,"version":"4.4.0"},"reference-count":26,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178319","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T17:29:29Z","timestamp":1496856569000},"page":"e0178319","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease"],"prefix":"10.1371","volume":"12","author":[{"given":"Mei-Yueh","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pi-Jung","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiun-Chi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hao","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1610-4184","authenticated-orcid":true,"given":"Szu-Chia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyi\u2013Jang","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"SR Seshasai","year":"2011","journal-title":"New Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies","volume":"375","author":"N Sarwar","year":"2010","journal-title":"Lancet"},{"key":"ref3","first-page":"45","article-title":"Postprandial hyperglycaemia: Noxious effects on the vessel wall","volume":"Suppl 129","author":"M Hanefeld","year":"2002","journal-title":"Int J Clin Pract"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (ukpds 35): Prospective observational study","volume":"321","author":"IM Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.jdiacomp.2004.10.001","article-title":"Should minimal blood glucose variability become the gold standard of glycemic control?","volume":"19","author":"IB Hirsch","year":"2005","journal-title":"J Diabetes Complications"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.295.14.1707","article-title":"Glycemic variability: A hemoglobin a1c-independent risk factor for diabetic complications","volume":"295","author":"M Brownlee","year":"2006","journal-title":"JAMA"},{"key":"ref7","first-page":"98","article-title":"Control of post-prandial hyperglycemia\u2014an essential part of good diabetes treatment and prevention of cardiovascular complications","volume":"12","author":"M Hanefeld","year":"2002","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12933-015-0233-0","article-title":"The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes","volume":"14","author":"JE Jun","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1007\/s00125-012-2572-7","article-title":"Hba(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba kawai diabetes registry 2","volume":"55","author":"A Sugawara","year":"2012","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1017 e1","DOI":"10.1016\/j.amjmed.2013.04.015","article-title":"Risks of diabetic nephropathy with variation in hemoglobin a1c and fasting plasma glucose","volume":"126","author":"CC Lin","year":"2013","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jdiacomp.2014.11.013","article-title":"Glycemic variability and diabetes retinopathy: A missing link","volume":"29","author":"CR Hsu","year":"2015","journal-title":"J Diabetes Complications"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jdiacomp.2016.05.024","article-title":"Association of variability in hemoglobin a1c with cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus\u2014a retrospective population-based cohort study","volume":"30","author":"EY Wan","year":"2016","journal-title":"J Diabetes Complications"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"JM Lachin","year":"2008","journal-title":"Diabetes"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"E924","DOI":"10.1152\/ajpendo.2001.281.5.E924","article-title":"Intermittent high glucose enhances apoptosis in human umbilical vein endothelial cells in culture","volume":"281","author":"A Risso","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2337\/diabetes.52.11.2795","article-title":"Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: The role of protein kinase c and nad(p)h-oxidase activation","volume":"52","author":"L Quagliaro","year":"2003","journal-title":"Diabetes"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1007\/s00125-009-1304-0","article-title":"Rapid 'glycaemic swings' induce nitrosative stress, activate poly(ADP-ribose) polymerase and impair endothelial function in a rat model of diabetes mellitus","volume":"52","author":"EM Horvath","year":"2009","journal-title":"Diabetologia"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"L Monnier","year":"2006","journal-title":"JAMA"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"A Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archinte.164.13.1445","article-title":"A probabilistic model for predicting hypoglycemia in type 2 diabetes mellitus: The Diabetes Outcomes in Veterans Study (DOVES)","volume":"164","author":"GH Murata","year":"2004","journal-title":"Arch Intern Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","article-title":"Intensive glycemic control and the prevention of cardiovascular events: Implications of the accord, advance, and va diabetes trials: A position statement of the american diabetes association and a scientific statement of the american college of cardiology foundation and the american heart association","volume":"53","author":"JS Skyler","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","article-title":"Hypoglycemia, diabetes, and cardiovascular events","volume":"33","author":"CV Desouza","year":"2010","journal-title":"Diabetes Care"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18381","DOI":"10.3390\/ijms151018381","article-title":"Glycemic variability and oxidative stress: A link between diabetes and cardiovascular disease?","volume":"15","author":"Y Saisho","year":"2014","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0272-6386(04)00951-5","article-title":"Red blood cell survival in chronic renal failure","volume":"44","author":"J Ly","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1744-9987.2009.00661.x","article-title":"Target for glycemic control in type 2 diabetic patients on hemodialysis: Effects of anemia and erythropoietin injection on hemoglobin a(1c)","volume":"13","author":"T Uzu","year":"2009","journal-title":"Ther Apher Dial"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.ajkd.2004.09.022","article-title":"The epidemiology of chronic kidney disease stages 1 to 4 and cardiovascular disease: A high-risk combination","volume":"45","author":"V Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1006524","article-title":"Long-term effects of intensive glucose lowering on cardiovascular outcomes","volume":"364","author":"HC Gerstein","year":"2011","journal-title":"New Engl J Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:29:49Z","timestamp":1659079789000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178319"}},"subtitle":[],"editor":[{"given":"Rayaz Ahmed","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178319","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}